Skip to main content
Springer Nature Link
Log in

Co-administration of Creatine Plus Pyruvate Prevents the Effects of Phenylalanine Administration to Female Rats During Pregnancy and Lactation on Enzymes Activity of Energy Metabolism in Cerebral Cortex and Hippocampus of the Offspring

  • Original Paper
  • Published:
Save article
View saved research
Neurochemical Research Aims and scope Submit manuscript

Abstract

Phenylketonuria (PKU) is the most frequent inborn error of metabolism. It is caused by deficiency in the activity of phenylalanine hydroxylase, leading to accumulation of phenylalanine and its metabolites. Untreated maternal PKU or hyperphenylalaninemia may result in nonphenylketonuric offspring with low birth weight and neonatal sequelae, especially microcephaly and intellectual disability. The mechanisms underlying the neuropathology of brain injury in maternal PKU syndrome are poorly understood. In the present study, we evaluated the possible preventive effect of the co-administration of creatine plus pyruvate on the effects elicited by phenylalanine administration to female Wistar rats during pregnancy and lactation on some enzymes involved in the phosphoryltransfer network in the brain cortex and hippocampus of the offspring at 21 days of age. Phenylalanine administration provoked diminution of body, brain cortex an hippocampus weight and decrease of adenylate kinase, mitochondrial and cytosolic creatine kinase activities. Co-administration of creatine plus pyruvate was effective in the prevention of those alterations provoked by phenylalanine, suggesting that altered energy metabolism may be important in the pathophysiology of maternal PKU. If these alterations also occur in maternal PKU, it is possible that pyruvate and creatine supplementation to the phenylalanine-restricted diet might be beneficial to phenylketonuric mothers.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Subscribe and save

Springer+
from $39.99 /Month
  • Starting from 10 chapters or articles per month
  • Access and download chapters and articles from more than 300k books and 2,500 journals
  • Cancel anytime
View plans

Buy Now

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
The alternative text for this image may have been generated using AI.
Fig. 2
The alternative text for this image may have been generated using AI.
Fig. 3
The alternative text for this image may have been generated using AI.
Fig. 4
The alternative text for this image may have been generated using AI.
Fig. 5
The alternative text for this image may have been generated using AI.
Fig. 6
The alternative text for this image may have been generated using AI.

Similar content being viewed by others

Explore related subjects

Discover the latest articles, books and news in related subjects, suggested using machine learning.

References

  1. Scriver CRKS (2001) Hyperphenylalaninemia: phenylalanine hydroxylase deficiency. In: Scriver CRBA, Sly WS, Valle D (eds) The metabolic & molecular bases of inherited diseases, 8th edn. McGraw-Hill, New York, pp 1667–1724

    Google Scholar 

  2. Kohli S, Saxena R, Thomas E, Rao P, Verma IC (2005) Prenatal diagnosis of phenylketonuria. Indian J Med Res 122:400–403

    CAS  PubMed  Google Scholar 

  3. Flydal MI, Martinez A (2013) Phenylalanine hydroxylase: function, structure, and regulation. IUBMB Life 65:341–349

    Article  CAS  PubMed  Google Scholar 

  4. Perez-Duenas B, Pujol J, Soriano-Mas C, Ortiz H, Artuch R, Vilaseca MA, Campistol J (2006) Global and regional volume changes in the brains of patients with phenylketonuria. Neurology 66:1074–1078

    Article  CAS  PubMed  Google Scholar 

  5. Surtees R, Blau N (2000) The neurochemistry of phenylketonuria. Eur J Pediatr 159(Suppl 2):S109–S113

    Article  CAS  PubMed  Google Scholar 

  6. Camp KM, Lloyd-Puryear MA, Huntington KL (2012) Nutritional treatment for inborn errors of metabolism: indications, regulations, and availability of medical foods and dietary supplements using phenylketonuria as an example. Mol Genet Metab 107:3–9

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  7. Lindegren ML, Krishnaswami S, Fonnesbeck C, Reimschisel T, Fisher J, Jackson K, Shields T, Sathe NA, McPheeters ML (2012) In: Adjuvant treatment for phenylketonuria (PKU). Rockville, MD

  8. Koch R, Burton B, Hoganson G, Peterson R, Rhead W, Rouse B, Scott R, Wolff J, Stern AM, Guttler F, Nelson M, de la Cruz F, Coldwell J, Erbe R, Geraghty MT, Shear C, Thomas J, Azen C (2002) Phenylketonuria in adulthood: a collaborative study. J Inherit Metab Dis 25:333–346

    Article  CAS  PubMed  Google Scholar 

  9. National Institutes of Health Consensus Development Panel (2001) National institutes of health consensus development conference statement: phenylketonuria: screening and management, October 16–18, 2000. Pediatrics 108:972–982

    Article  Google Scholar 

  10. Berry SA, Brown C, Grant M, Greene CL, Jurecki E, Koch J, Moseley K, Suter R, van Calcar SC, Wiles J, Cederbaum S (2013) Newborn screening 50 years later: access issues faced by adults with PKU. Genet Med 15:591–599

    Article  PubMed Central  PubMed  Google Scholar 

  11. Didycz B, Domagala L, Pietrzyk JJ (2009) The maternal phenylketonuria syndrom—still current problem. Przegl Lek 66:4–10

    PubMed  Google Scholar 

  12. Diamond A, Prevor MB, Callender G, Druin DP (1997) Prefrontal cortex cognitive deficits in children treated early and continuously for PKU. Monogr Soc Res Child Dev 62:i–v, 1–208

  13. Schulpis KH, Papassotiriou I, Vounatsou M, Karikas GA, Tsakiris S, Chrousos GP (2004) Morning preprandial plasma ghrelin and catecholamine concentrations in patients with phenylketonuria and normal controls: evidence for catecholamine-mediated ghrelin regulation. J Clin Endocrinol Metab 89:3983–3987

    Article  CAS  PubMed  Google Scholar 

  14. McPheeters ML, Lindegren ML, Sathe N, Reimschisel T (2012) Adjuvant treatment for phenylketonuria. Future research needs: identification of future research needs from comparative effectiveness review no 56. Agency for Healthcare Research and Quality, Rockville, MD

  15. Desagher S, Glowinski J, Premont J (1997) Pyruvate protects neurons against hydrogen peroxide-induced toxicity. J Neurosci 17:9060–9067

    CAS  PubMed  Google Scholar 

  16. Mazzio E, Soliman KF (2003) Pyruvic acid cytoprotection against 1-methyl-4-phenylpyridinium, 6-hydroxydopamine and hydrogen peroxide toxicities in vitro. Neurosci Lett 337:77–80

    CAS  PubMed  Google Scholar 

  17. Sestili P, Martinelli C, Bravi G, Piccoli G, Curci R, Battistelli M, Falcieri E, Agostini D, Gioacchini AM, Stocchi V (2006) Creatine supplementation affords cytoprotection in oxidatively injured cultured mammalian cells via direct antioxidant activity. Free Radic Biol Med 40:837–849

    Article  CAS  PubMed  Google Scholar 

  18. Kraemer WJ, Volek JS (1999) Creatine supplementation. Its role in human performance. Clin Sports Med 18:651–666, ix

  19. Lawler JM, Barnes WS, Wu G, Song W, Demaree S (2002) Direct antioxidant properties of creatine. Biochem Biophys Res Commun 290:47–52

    Article  CAS  PubMed  Google Scholar 

  20. Sartini S, Sestili P, Colombo E, Martinelli C, Bartolini F, Ciuffoli S, Lattanzi D, Sisti D, Cuppini R (2012) Creatine affects in vitro electrophysiological maturation of neuroblasts and protects them from oxidative stress. J Neurosci Res 90:435–446

    Article  CAS  PubMed  Google Scholar 

  21. Ferrante RJ, Andreassen OA, Jenkins BG, Dedeoglu A, Kuemmerle S, Kubilus JK, Kaddurah-Daouk R, Hersch SM, Beal MF (2000) Neuroprotective effects of creatine in a transgenic mouse model of Huntington’s disease. J Neurosci 20:4389–4397

    CAS  PubMed  Google Scholar 

  22. Matthews RT, Ferrante RJ, Klivenyi P, Yang L, Klein AM, Mueller G, Kaddurah-Daouk R, Beal MF (1999) Creatine and cyclocreatine attenuate MPTP neurotoxicity. Exp Neurol 157:142–149

    Article  CAS  PubMed  Google Scholar 

  23. Beal MF (2011) Neuroprotective effects of creatine. Amino Acids 40:1305–1313

    Article  CAS  PubMed  Google Scholar 

  24. Dos Reis EA, Rieger E, de Souza SS, Rasia-Filho AA, Wannmacher CM (2013) Effects of a co-treatment with pyruvate and creatine on dendritic spines in rat hippocampus and posterodorsal medial amygdala in a phenylketonuria animal model. Metab Brain Dis 28:509–517

    Article  CAS  PubMed  Google Scholar 

  25. Berti SL, Nasi GM, Garcia C, Castro FL, Nunes ML, Rojas DB, Moraes TB, Dutra-Filho CS, Wannmacher CM (2012) Pyruvate and creatine prevent oxidative stress and behavioral alterations caused by phenylalanine administration into hippocampus of rats. Metab Brain Dis 27:79–89

    Article  CAS  PubMed  Google Scholar 

  26. Mochel F, Durant B, Meng X, O’Callaghan J, Yu H, Brouillet E, Wheeler VC, Humbert S, Schiffmann R, Durr A (2012) Early alterations of brain cellular energy homeostasis in Huntington disease models. J Biol Chem 287:1361–1370

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  27. Beal MF (1995) Aging, energy, and oxidative stress in neurodegenerative diseases. Ann Neurol 38:357–366

    Article  CAS  PubMed  Google Scholar 

  28. Beal MF (2000) Energetics in the pathogenesis of neurodegenerative diseases. Trends Neurosci 23:298–304

    Article  CAS  PubMed  Google Scholar 

  29. Nissenkorn A, Michelson M, Ben-Zeev B, Lerman-Sagie T (2001) Inborn errors of metabolism: a cause of abnormal brain development. Neurology 56:1265–1272

    Article  CAS  PubMed  Google Scholar 

  30. Costabeber E, Kessler A, Severo Dutra-Filho C, de Souza Wyse AT, Wajner M, Wannmacher CM (2003) Hyperphenylalaninemia reduces creatine kinase activity in the cerebral cortex of rats. Int J Dev Neurosci 21:111–116

    Article  CAS  PubMed  Google Scholar 

  31. Cornelio AR, Rodrigues V Jr, de Souza Wyse AT, Dutra-Filho CS, Wajner M, Wannmacher CM (2004) Tryptophan reduces creatine kinase activity in the brain cortex of rats. Int J Dev Neurosci 22:95–101

    Article  CAS  PubMed  Google Scholar 

  32. Feksa LR, Cornelio AR, Vargas CR, de Souza Wyse AT, Dutra-Filho CS, Wajner M, Wannmacher CM (2003) Alanine prevents the inhibition of pyruvate kinase activity caused by tryptophan in cerebral cortex of rats. Metab Brain Dis 18:129–137

    Article  CAS  PubMed  Google Scholar 

  33. Kessler A, Costabeber E, Dutra-Filho CS, Wyse AT, Wajner M, Wannmacher CM (2003) Proline reduces creatine kinase activity in the brain cortex of rats. Neurochem Res 28:1175–1180

    Article  CAS  PubMed  Google Scholar 

  34. Pilla C, de Oliveira Cardozo RF, Dutra-Filho CS, Wyse AT, Wajner M, Wannmacher CM (2003) Effect of leucine administration on creatine kinase activity in rat brain. Metab Brain Dis 18:17–25

    Article  CAS  PubMed  Google Scholar 

  35. Rech VC, Feksa LR, Fleck RM, Athaydes GA, Dornelles PK, Rodrigues-Junior V, Wannmacher CM (2008) Cysteamine prevents inhibition of thiol-containing enzymes caused by cystine or cystine dimethylester loading in rat brain cortex. Metab Brain Dis 23:133–145

    Article  CAS  PubMed  Google Scholar 

  36. de Andrade RB, Gemelli T, Rojas DB, Funchal C, Dutra-Filho CS, Wannmacher CM (2012) Tyrosine impairs enzymes of energy metabolism in cerebral cortex of rats. Mol Cell Biochem 364:253–261

    Article  CAS  PubMed  Google Scholar 

  37. Rojas DB, de Andrade RB, Gemelli T, Oliveira LS, Campos AG, Dutra-Filho CS, Wannmacher CM (2012) Effect of histidine administration to female rats during pregnancy and lactation on enzymes activity of phosphoryltransfer network in cerebral cortex and hippocampus of the offspring. Metab Brain Dis 27:595–603

    Article  CAS  PubMed  Google Scholar 

  38. Stockler S, Holzbach U, Hanefeld F, Marquardt I, Helms G, Requart M, Hanicke W, Frahm J (1994) Creatine deficiency in the brain: a new, treatable inborn error of metabolism. Pediatr Res 36:409–413

    Article  CAS  PubMed  Google Scholar 

  39. Ryu JK, Choi HB, McLarnon JG (2006) Combined minocycline plus pyruvate treatment enhances effects of each agent to inhibit inflammation, oxidative damage, and neuronal loss in an excitotoxic animal model of Huntington’s disease. Neuroscience 141:1835–1848

    Article  CAS  PubMed  Google Scholar 

  40. Feksa LR, Cornelio AR, Rech VC, Dutra-Filho CS, Wyse AT, Wajner M, Wannmacher CM (2002) Alanine prevents the reduction of pyruvate kinase activity in brain cortex of rats subjected to chemically induced hyperphenylalaninemia. Neurochem Res 27:947–952

    Article  CAS  PubMed  Google Scholar 

  41. Hughes BP (1962) A method for the estimation of serum creatine kinase and its use in comparing creatine kinase and aldolase activity in normal and pathological sera. Clin Chim Acta 7:597–603

    Article  CAS  PubMed  Google Scholar 

  42. Dzeja PP, Vitkevicius KT, Redfield MM, Burnett JC, Terzic A (1999) Adenylate kinase-catalyzed phosphotransfer in the myocardium: increased contribution in heart failure. Circ Res 84:1137–1143

    Article  CAS  PubMed  Google Scholar 

  43. Leong SFLJ, Lim L, Clark JB (1981) Energy-metabolizing enzymes in brain regions of adult and aging rats. J Neurochem 37:1548–1556

    Article  CAS  PubMed  Google Scholar 

  44. Lowry OH, Rosebrough NJ, Farr AL, Randall RJ (1951) Protein measurement with the Folin phenol reagent. J Biol Chem 193:265–275

    CAS  PubMed  Google Scholar 

  45. Moraes TB, Zanin F, da Rosa A, de Oliveira A, Coelho J, Petrillo F, Wajner M, Dutra-Filho CS (2010) Lipoic acid prevents oxidative stress in vitro and in vivo by an acute hyperphenylalaninemia chemically-induced in rat brain. J Neurol Sci 292:89–95

    Article  CAS  PubMed  Google Scholar 

  46. Skvorak KJ (2009) Animal models of maple syrup urine disease. J Inherit Metab Dis 32:229–246

    Article  CAS  PubMed  Google Scholar 

  47. Lutz Mda G, Feksa LR, Wyse AT, Dutra-Filho CS, Wajner M, Wannmacher CM (2003) Alanine prevents the in vitro inhibition of glycolysis caused by phenylalanine in brain cortex of rats. Metab Brain Dis 18:87–94

    Article  PubMed  Google Scholar 

  48. Pietz J, Rupp A, Ebinger F, Rating D, Mayatepek E, Boesch C, Kreis R (2003) Cerebral energy metabolism in phenylketonuria: findings by quantitative in vivo 31P MR spectroscopy. Pediatr Res 53:654–662

    Article  PubMed  Google Scholar 

  49. Granett SE, Wells WW (1972) Energy metabolism in the brains of l-phenylalanine-treated chicks. J Neurochem 19:1089–1098

    Article  CAS  PubMed  Google Scholar 

  50. Glazer RI, Weber G (1971) The effects of l-phenylalanine and phenylpyruvate on glycolysis in rat cerebral cortex. Brain Res 33:439–450

    Article  CAS  PubMed  Google Scholar 

  51. Saks V, Dzeja P, Schlattner U, Vendelin M, Terzic A, Wallimann T (2006) Cardiac system bioenergetics: metabolic basis of the Frank–Starling law. J Physiol 571:253–273

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  52. Dzeja PP, Redfield MM, Burnett JC, Terzic A (2000) Failing energetics in failing hearts. Curr Cardiol Rep 2:212–217

    Article  CAS  PubMed  Google Scholar 

  53. Dzeja PP, Terzic A (2003) Phosphotransfer networks and cellular energetics. J Exp Biol 206:2039–2047

    Article  CAS  PubMed  Google Scholar 

  54. Dzeja PP, Zeleznikar RJ, Goldberg ND (1998) Adenylate kinase: kinetic behavior in intact cells indicates it is integral to multiple cellular processes. Mol Cell Biochem 184:169–182

    Article  CAS  PubMed  Google Scholar 

  55. Wallimann T, Wyss M, Brdiczka D, Nicolay K, Eppenberger HM (1992) Intracellular compartmentation, structure and function of creatine kinase isoenzymes in tissues with high and fluctuating energy demands: the ‘phosphocreatine circuit’ for cellular energy homeostasis. Biochem J 281(Pt 1):21–40

    CAS  PubMed Central  PubMed  Google Scholar 

  56. Saks VA, Khuchua ZA, Vasilyeva EV, Belikova O, Kuznetsov AV (1994) Metabolic compartmentation and substrate channelling in muscle cells. Role of coupled creatine kinases in vivo regulation of cellular respiration—a synthesis. Mol Cell Biochem 133–134:155–192

    Article  PubMed  Google Scholar 

  57. Dzeja P, Terzic A (2009) Adenylate kinase and AMP signaling networks: metabolic monitoring, signal communication and body energy sensing. Int J Mol Sci 10:1729–1772

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  58. Chung S, Arrell DK, Faustino RS, Terzic A, Dzeja PP (2010) Glycolytic network restructuring integral to the energetics of embryonic stem cell cardiac differentiation. J Mol Cell Cardiol 48:725–734

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  59. Gilbert HF (1984) Redox control of enzyme activities by thiol/disulfide exchange. Methods Enzymol 107:330–351

    Article  CAS  PubMed  Google Scholar 

  60. Tonin AM, Ferreira GC, Schuck PF, Viegas CM, Zanatta A, Leipnitz G, Seminotti B, Duvall Wannmacher CM, Wajner M (2009) Inhibition of creatine kinase activity by lysine in rat cerebral cortex. Metab Brain Dis 24:349–360

    Article  CAS  PubMed  Google Scholar 

  61. Figueiredo VC, Feksa LR, Wannmacher CM (2009) Cysteamine prevents inhibition of adenylate kinase caused by cystine in rat brain cortex. Metab Brain Dis 24:373–381

    Article  CAS  PubMed  Google Scholar 

  62. Andrade VS, Rojas DB, Oliveira L, Nunes ML, de Castro FL, Garcia C, Gemelli T, de Andrade RB, Wannmacher CM (2012) Creatine and pyruvate prevent behavioral and oxidative stress alterations caused by hypertryptophanemia in rats. Mol Cell Biochem 362:225–232

    Article  CAS  PubMed  Google Scholar 

  63. Kienzle Hagen ME, Pederzolli CD, Sgaravatti AM, Bridi R, Wajner M, Wannmacher CM, Wyse AT, Dutra-Filho CS (2002) Experimental hyperphenylalaninemia provokes oxidative stress in rat brain. Biochim Biophys Acta 1586:344–352

    Article  CAS  PubMed  Google Scholar 

  64. Rae C, Digney AL, McEwan SR, Bates TC (2003) Oral creatine monohydrate supplementation improves brain performance: a double-blind, placebo-controlled, cross-over trial. Proc Biol Sci R Soc 270:2147–2150

    Article  CAS  Google Scholar 

  65. Feksa LR, Cornelio AR, Dutra-Filho CS, de Souza Wyse AT, Wajner M, Wannmacher CM (2003) Characterization of the inhibition of pyruvate kinase caused by phenylalanine and phenylpyruvate in rat brain cortex. Brain Res 968:199–205

    Article  CAS  PubMed  Google Scholar 

  66. Miller AL, Hawkins RA, Veech RL (1973) Phenylketonuria: phenylalanine inhibits brain pyruvate kinase in vivo. Science 179:904–906

    Article  CAS  PubMed  Google Scholar 

  67. Williams R, Holyoak T, McDonald G, Gui C, Fenton AW (2006) Differentiating a ligand’s chemical requirements for allosteric interactions from those for protein binding. Phenylalanine inhibition of pyruvate kinase. Biochemistry 45:5421–5429

    Article  CAS  PubMed  Google Scholar 

  68. Pucar D, Dzeja PP, Bast P, Gumina RJ, Drahl C, Lim L, Juranic N, Macura S, Terzic A (2004) Mapping hypoxia-induced bioenergetic rearrangements and metabolic signaling by 18O-assisted 31P NMR and 1H NMR spectroscopy. Mol Cell Biochem 256–257:281–289

    Article  PubMed Central  PubMed  Google Scholar 

Download references

Acknowledgments

This work was supported by the research grants from Coordenação de Aperfeiçoamento de Pessoal de Nível Superior (CAPES), Conselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq), Fundação de Amparo à Pesquisa do Estado do Rio Grande do Sul (FAPERGS) and FINEP Rede Instituto Brasileiro de Neurociência.

Author information

Authors and Affiliations

  1. Departamento de Bioquímica, Programa de Pós-Graduação em Ciências Biológicas: Bioquímica, Instituto de Ciências Básicas da Saúde, Universidade Federal do Rio Grande do Sul, Rua Ramiro Barcelos, 2600 anexo, Porto Alegre, RS, 90035-003, Brazil

    Vanessa Trindade Bortoluzzi, Itiane Diehl de Franceschi, Elenara Rieger & Clóvis Milton Duval Wannmacher

Authors
  1. Vanessa Trindade Bortoluzzi
    View author publications

    Search author on:PubMed Google Scholar

  2. Itiane Diehl de Franceschi
    View author publications

    Search author on:PubMed Google Scholar

  3. Elenara Rieger
    View author publications

    Search author on:PubMed Google Scholar

  4. Clóvis Milton Duval Wannmacher
    View author publications

    Search author on:PubMed Google Scholar

Corresponding author

Correspondence to Clóvis Milton Duval Wannmacher.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Bortoluzzi, V.T., de Franceschi, I.D., Rieger, E. et al. Co-administration of Creatine Plus Pyruvate Prevents the Effects of Phenylalanine Administration to Female Rats During Pregnancy and Lactation on Enzymes Activity of Energy Metabolism in Cerebral Cortex and Hippocampus of the Offspring. Neurochem Res 39, 1594–1602 (2014). https://doi.org/10.1007/s11064-014-1353-8

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue date:

  • DOI: https://doi.org/10.1007/s11064-014-1353-8

Keywords